Please use this identifier to cite or link to this item: https://doi.org/10.1007/s40258-021-00661-5
Title: Avoiding Trouble Ahead: Lessons Learned and Suggestions for Economic Evaluations of COVID-19 Vaccines
Authors: Painter, Chris
Isaranuwatchai, Wanrudee
Prawjaeng, Juthamas
Wee, Hwee Lin 
Chua, Brandon Wen Bing 
Huynh, Vinh Anh 
Lou, Jing 
Goh, Fang Ting
Luangasanatip, Nantasit
Pan-Ngum, Wirichada
Yi, Wang 
Clapham, Hannah 
Teerawattananon, Yot 
Keywords: Social Sciences
Science & Technology
Life Sciences & Biomedicine
Economics
Health Care Sciences & Services
Health Policy & Services
Business & Economics
COST-EFFECTIVENESS
VACCINATION
HEALTH
UK
Issue Date: 1-Jul-2021
Publisher: SPRINGER INT PUBL AG
Citation: Painter, Chris, Isaranuwatchai, Wanrudee, Prawjaeng, Juthamas, Wee, Hwee Lin, Chua, Brandon Wen Bing, Huynh, Vinh Anh, Lou, Jing, Goh, Fang Ting, Luangasanatip, Nantasit, Pan-Ngum, Wirichada, Yi, Wang, Clapham, Hannah, Teerawattananon, Yot (2021-07-01). Avoiding Trouble Ahead: Lessons Learned and Suggestions for Economic Evaluations of COVID-19 Vaccines. APPLIED HEALTH ECONOMICS AND HEALTH POLICY 19 (4) : 463-472. ScholarBank@NUS Repository. https://doi.org/10.1007/s40258-021-00661-5
Abstract: With vaccines for coronavirus disease 2019 (COVID-19) being introduced in countries across the world, policy makers are facing many practical considerations about how best to implement a vaccination programme. The supply of vaccines is insufficient for the global population, so decisions must be made as to which groups are prioritised for any vaccination and when. Furthermore, the aims of vaccination programmes will differ between countries, with some prioritising economic benefits that could stem from the relaxation of non-pharmaceutical interventions and others seeking simply to reduce the number of COVID-19 cases or deaths. This paper aims to share the experiences and lessons learned from conducting economic evaluations in Singapore and Thailand on hypothetical COVID-19 vaccines to provide a basis for other countries to develop their own contextualised economic evaluations, with particular focus on the key uncertainties, technical challenges, and characteristics that modellers should consider in partnership with key stakeholders. Which vaccines, vaccination strategies, and policy responses are most economically beneficial remains uncertain. It is therefore important for all governments to conduct their own analyses to inform local policy responses to COVID-19, including the implementation of COVID-19 vaccines in both the short and the long run. It is essential that such studies are designed, and ideally conducted, before vaccines are introduced so that policy decisions and implementation procedures are not delayed.
Source Title: APPLIED HEALTH ECONOMICS AND HEALTH POLICY
URI: https://scholarbank.nus.edu.sg/handle/10635/227777
ISSN: 11755652
11791896
DOI: 10.1007/s40258-021-00661-5
Appears in Collections:Staff Publications
Elements

Show full item record
Files in This Item:
File Description SizeFormatAccess SettingsVersion 
Avoiding Trouble Ahead Lessons Learned and Suggestions for Economic Evaluations of COVID-19 Vaccines.pdf1.51 MBAdobe PDF

OPEN

PublishedView/Download

SCOPUSTM   
Citations

2
checked on Aug 12, 2022

Page view(s)

20
checked on Aug 4, 2022

Download(s)

1
checked on Aug 4, 2022

Google ScholarTM

Check

Altmetric


Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.